DK3672962T3 - Morpholinylpyridonforbindelser - Google Patents

Morpholinylpyridonforbindelser Download PDF

Info

Publication number
DK3672962T3
DK3672962T3 DK18759105.2T DK18759105T DK3672962T3 DK 3672962 T3 DK3672962 T3 DK 3672962T3 DK 18759105 T DK18759105 T DK 18759105T DK 3672962 T3 DK3672962 T3 DK 3672962T3
Authority
DK
Denmark
Prior art keywords
morpholinylpyridone
compounds
morpholinylpyridone compounds
Prior art date
Application number
DK18759105.2T
Other languages
English (en)
Inventor
Johan Lindström
Rickard Forsblom
Jenny Viklund
Original Assignee
Sprint Bioscience Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sprint Bioscience Ab filed Critical Sprint Bioscience Ab
Application granted granted Critical
Publication of DK3672962T3 publication Critical patent/DK3672962T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
DK18759105.2T 2017-08-23 2018-08-23 Morpholinylpyridonforbindelser DK3672962T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17187567 2017-08-23
PCT/EP2018/072791 WO2019038390A1 (en) 2017-08-23 2018-08-23 MORPHOLINYLPYRIDONE COMPOUNDS

Publications (1)

Publication Number Publication Date
DK3672962T3 true DK3672962T3 (da) 2022-05-02

Family

ID=59686888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18759105.2T DK3672962T3 (da) 2017-08-23 2018-08-23 Morpholinylpyridonforbindelser

Country Status (19)

Country Link
US (2) US11560374B2 (da)
EP (2) EP4056569A1 (da)
JP (2) JP7199736B2 (da)
KR (1) KR20200044025A (da)
CN (3) CN111108102B (da)
AU (2) AU2018320419B2 (da)
CA (1) CA3073142A1 (da)
DK (1) DK3672962T3 (da)
ES (1) ES2910157T3 (da)
HR (1) HRP20220497T1 (da)
HU (1) HUE058661T2 (da)
IL (3) IL302077A (da)
LT (1) LT3672962T (da)
PL (1) PL3672962T3 (da)
PT (1) PT3672962T (da)
RS (1) RS63109B1 (da)
SI (1) SI3672962T1 (da)
TW (2) TW202348601A (da)
WO (1) WO2019038390A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117241829A (zh) * 2020-11-25 2023-12-15 德西费拉制药有限责任公司 Vps34抑制剂的抗病毒活性

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130130030A (ko) 2010-12-21 2013-11-29 노파르티스 아게 Vps34 억제제로서의 비-헤테로아릴 화합물
DK2655375T3 (da) * 2010-12-23 2015-03-09 Sanofi Sa Pyrimidinonderivater, fremstilling og farmaceutisk anvendelse heraf
GB201120317D0 (en) 2011-11-24 2012-01-04 Queen Mary & Westfield College Screening method
FR2992314B1 (fr) 2012-06-22 2015-10-16 Sanofi Sa Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one et 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one comportant une morpholine substituee, leur preparation et leur utilisation pharmaceutique
JP6074043B2 (ja) * 2013-08-29 2017-02-01 富士フイルム株式会社 新規なモルホリン誘導体またはその塩
KR20160122736A (ko) 2014-01-14 2016-10-24 밀레니엄 파머슈티컬스 인코퍼레이티드 헤테로아릴 및 이의 용도
EP3094326A4 (en) 2014-01-14 2017-07-26 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
MA39823A (fr) 2014-04-03 2018-01-09 Janssen Pharmaceutica Nv Dérivés de pyridine macrocyclique
MA39822A (fr) 2014-04-03 2018-02-06 Janssen Pharmaceutica Nv Dérivés de pyrimidine bicycle
WO2017009751A1 (en) 2015-07-15 2017-01-19 Pfizer Inc. Pyrimidine derivatives
RS60900B1 (sr) * 2016-02-19 2020-11-30 Sprint Bioscience Ab Jedinjenja 6-heterociklil-4-morfolin-4-ilpiridin-2-ona korisna za lečenje kancera i dijabetesa
SI3416945T1 (sl) 2016-02-19 2020-11-30 Sprint Bioscience Ab Spojine 6-aril-4-(morfolin-4-IL)-1H-piridin-2-ona, uporabne za zdravljenje raka in diabetesa

Also Published As

Publication number Publication date
RU2020110506A (ru) 2021-09-23
US20230234949A1 (en) 2023-07-27
JP2023021268A (ja) 2023-02-10
EP4056569A1 (en) 2022-09-14
HRP20220497T1 (hr) 2022-05-27
CA3073142A1 (en) 2019-02-28
HUE058661T2 (hu) 2022-09-28
WO2019038390A1 (en) 2019-02-28
RU2020110506A3 (da) 2022-02-22
IL292489B2 (en) 2023-09-01
CN111108102B (zh) 2023-04-28
IL292489A (en) 2022-06-01
CN111108102A (zh) 2020-05-05
AU2018320419B2 (en) 2023-09-28
TW201912161A (zh) 2019-04-01
JP2020531485A (ja) 2020-11-05
ES2910157T3 (es) 2022-05-11
IL272815A (en) 2020-04-30
JP7199736B2 (ja) 2023-01-06
EP3672962B1 (en) 2022-01-26
RS63109B1 (sr) 2022-04-29
EP3672962A1 (en) 2020-07-01
IL272815B (en) 2022-06-01
TW202348601A (zh) 2023-12-16
AU2023285995A1 (en) 2024-01-25
US11560374B2 (en) 2023-01-24
KR20200044025A (ko) 2020-04-28
TWI803511B (zh) 2023-06-01
LT3672962T (lt) 2022-05-10
IL292489B1 (en) 2023-05-01
AU2018320419A1 (en) 2020-04-09
CN116462674A (zh) 2023-07-21
IL302077A (en) 2023-06-01
CN116444510A (zh) 2023-07-18
SI3672962T1 (sl) 2022-06-30
PT3672962T (pt) 2022-04-12
PL3672962T3 (pl) 2022-05-02
US20200361922A1 (en) 2020-11-19

Similar Documents

Publication Publication Date Title
DK3731771T3 (da) V462033dk00
DE202018003363U8 (de) Handgelenkssphygmomanometer
CL2018000524S1 (es) Golilla
DK3351526T3 (da) Diisopentylterephthalat
DK3612519T3 (da) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser
DK3568655T3 (da) Rekuperator
DK3571580T5 (da) Load-logical-and-shift-guarded-instruktion
DK3612237T3 (da) Genterapi
DK3568506T3 (da) Offeranode
DK3672941T3 (da) Pyridylpyridonforbindelser
DK3576686T3 (da) Brokbind
DK3676276T3 (da) Spirothietannukleosider
DK3576718T3 (da) Pastil
FI11704U1 (fi) Liittopuujärjestely
DK3672962T3 (da) Morpholinylpyridonforbindelser
DK3510051T3 (da) Carboxylalkylchitosan
DK3395159T3 (da) Ballepresse
ES1205411Y (es) Maleta-Gaveta
ES1198359Y (es) Columbario
FI11529U1 (fi) Ontelolaatan kannake
DK3645955T3 (da) Buffertank
DK3401461T3 (da) Falsetagtegl
DK3391735T3 (da) Ballepresse
DK3391733T3 (da) Ballepresse
UA37486S (uk) Опакування - етикетка для міні-круасанів